EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 3.0

Mesenchymal Stem Cell Therapy for rheumatic diseases

Winnie Wan-Yin Yeung, Chak-Sing Lau

Hong Kong Bulletin on Rheumatic Diseases · 2016

DOI: 10.1515/hkbrd-2016-0002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hong Kong Bulletin on Rheumatic Diseases, 2016. Verfasst von Winnie Wan-Yin Yeung und 1 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesenchymal stem cell therapy (MSCT) is an innovative treatment for rheumatic diseases. Underlying mechanism of how MSCT works in rheumatic diseases are still uncertain and with various hypotheses. Animal studies in MSCT show conflicting results mainly attributed by the differences in administration methods of MSCT, types of MSC use and randomization procedures. Human studies of MSCT are so far small scale but with satisfactory results in patients with systemic lupus erythematosus (SLE). Human studies of MSCT, however, showed less rewarding results in patients with rheumatoid arthritis (RA) and systemic sclerosis (SSc). Larger scale studies are needed to confirm the efficiency of MSCT as well as the safety profile in human use.

Zitieren

APA

Yeung, W. W., & Lau, C. (2016). Mesenchymal Stem Cell Therapy for rheumatic diseases. Hong Kong Bulletin on Rheumatic Diseases. https://doi.org/10.1515/hkbrd-2016-0002

Vancouver

Yeung WW, Lau C. Mesenchymal Stem Cell Therapy for rheumatic diseases. Hong Kong Bulletin on Rheumatic Diseases. 2016. doi:10.1515/hkbrd-2016-0002

BibTeX
@article{Yeung2016,
  author = {Yeung, Winnie Wan-Yin and Lau, Chak-Sing},
  title = {Mesenchymal Stem Cell Therapy for rheumatic diseases},
  journal = {Hong Kong Bulletin on Rheumatic Diseases},
  year = {2016},
  doi = {10.1515/hkbrd-2016-0002}
}
Kostenlos starten →